Comprehensive care for this complex disease
Pulmonary hypertension is a dangerous and complex condition. Our partnership with the National Institutes of Health means our patients have access to diagnostic testing and clinical trials that aren’t available anywhere else. We also partner with the Pulmonary Hypertension Association to provide patients and their caretakers with much-needed support during treatment that may range from complex medication therapy to transplant of the lungs and heart.
Our expertise allows us to care for rare and complex conditions, such as pulmonary arterial hypertension (PAH). This disease can be fatal rapidly without special medications that require close monitoring by heart specialists.
Have questions for our heart and vascular program? Email us at AskMHVI@medstar.net.